Europe Spinal Cord Stimulation Device for Chronic Pain Market Forecast to 2030

Europe Spinal Cord Stimulation Device for Chronic Pain Market Forecast to 2030

Europe Spinal Cord Stimulation Device for Chronic Pain Market Forecast to 2030 – Regional Analysis – by Product Type (Rechargeable and Non-Rechargeable), Application (Failed Back Syndrome, Complex Regional Pain Syndrome, Degenerative Disk Disease, and Others), and End User (Hospitals, Ambulatory Surgery Centers, and Others)

Send Enquiry
Item ID: BMIRE00030432 Category: Tag:

$2,485 – $3,885

Description

The spinal cord stimulation device for chronic pain market was valued at US$ 799.87 million in 2022 and is expected to reach US$ 1,412.01 million by 2030; it is estimated to register at a CAGR of 7.4% from 2022 to 2030.

Rehabilitation and Specialized Centers Providing Effective Treatment for Spinal Cord Injuries Fuels Spinal Cord Stimulation Device for Chronic Pain Market

According to a report by the NIH, specialized centers of care for SCI were first established in England with an objective to improve the care and neurological recovery of patients. SCI tertiary care centers are developed to improve clinical outcomes and neurological recovery among patients suffering from acute SCIs. Additionally, the Spinal Cord Injury Center at Heidelberg University Hospital in Germany is the only academic center dedicated to the treatment and research of SCIs. The staff at Heidelberg University Hospital, including ~145 staff members, provides treatment to ~1,500 patients suffering from acute or chronic spinal cord injuries annually, among which 1,000 receive outpatient care.

Spinal cord stimulation devices are highly adopted in rehabilitation centers. A treatment method based on these devices supports patients physically and psychologically to maximize their neurological recovery and general health in a short time. The Walk Again Center based in Berlin is one such example of a rehabilitation center to treat neurological conditions. This rehab center employs both medicine and technology to treat SCIs. It uses innovative medical procedures, including structural and neural neuroplasticity, where doctors provide therapy to patients suffering from brain damage. Therefore, advanced rehab centers and specialized centers provide growth opportunities to the Europe spinal cord stimulation devices for chronic pain market.

Europe Spinal Cord Stimulation Device for Chronic Pain Market Overview

Europe spinal cord stimulation device for chronic pain market by region, is segmented as Germany, France, Italy, Spain, United Kingdom, Switzerland, Netherlands, Sweden, and Rest of Europe. The rising healthcare claims and associated costs, increasing administrative transactions, and spinal cord stimulation device for chronic pain platform in supply chain tracking are among the prominent factors propelling the market growth. for instance, in Italy, spinal cord treatments in hospitals are fully covered under insurance through the Italian National Health System (NHS). Therefore, there is high awareness of effective treatments available for SCIs among the Italian population. Therefore, the availability of proper health coverage provisions for SCI signifies a high demand for spinal cord stimulation devices among hospitals and specialty centers in Italy.

Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue and forecast to 2030 (US$ Million)

Europe Spinal Cord Stimulation Device for Chronic Pain Market Segmentation

The spinal cord stimulation device for chronic pain market is segmented based on product type, application, end user, and country.

Based on product type, the spinal cord stimulation device for chronic pain market is bifurcated into rechargeable and non-rechargeable. The rechargeable segment held a larger share in 2022.

In terms of application, the spinal cord stimulation device for chronic pain market is segmented into failed back syndrome, complex regional pain syndrome, degenerative disk disease, and others. The complex regional pain syndrome segment held the largest share in 2022.

By end user, the spinal cord stimulation device for chronic pain market is segmented into hospitals, ambulatory surgery centers (ASCS), and others. The hospitals segment held the largest share in 2022.

Based on country, the spinal cord stimulation device for chronic pain market is categorized into Germany, France, the UK, Spain, Italy, Switzerland, Sweden, Poland, Belgium, Slovakia, Czech Republic, Greece, Ireland, the Netherland, and the Rest of Europe. Germany dominated the spinal cord stimulation device for chronic pain market in 2022.

Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE & Co KG, Nevro Corp, Cirtec Medical Corp, and Synapse Biomedical Inc are some of the leading companies operating in the Europe spinal cord stimulation device for chronic pain market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 7.4% CAGR, Europe Spinal Cord Stimulation Device for Chronic Pain Market is Speculated to be Worth US$ 1,412.01 Million by 2030, says the Research Team

According to the Research Team’ research, the Europe spinal cord stimulation device for chronic pain market was valued at US$ 799.87 million in 2022 and is expected to reach US$ 1,412.01 million by 2030, registering a CAGR of 7.4% from 2022 to 2030. Rising number of spinal cord injuries and availability of innovative treatments in European union are among the critical factors attributed to the Europe spinal cord stimulation device for chronic pain market expansion.

According to a report published by the Association for Spinal Injury Research, Rehabilitation and Reintegration (Aspire, UK), ~2,500 people are diagnosed with spinal cord injuries (SCIs) annually in the UK. Currently, ~50,000 people are living with SCIs in the country. An elevated number of cases is attributed to emerging motocross and motorcycling competitions as the most popular sporting activities in the UK, as per the National Institute of Health (NIH) report. With rising motor sporting activities among the youth and senior age group population, there is an increase in the incidence of SCIs among the participants of these events. SCIs have life-changing impacts on the injured patients and their families. Owing to the rising incidence of SCIs, results in at least one readmission of the patient every year. This is because SCIs are not treated at once. The causes of rehospitalization include respiratory and urinary tract infections, and fractures occurring during motorcycling sports activities.

The London Spinal Cord Injury Center (LSCIC) is 1 of the 11 organizations in the UK dedicated to treating SCI patients. At the LSCIC, patients undergo a rehabilitation program that takes years and is best delivered through lifelong intervention. With rising SCI and the availability of a well-developed infrastructure in treatment centers providing rehabilitation programs, demand for spinal cord stimulation devices is surging in specialized or rehab centers, which fuels the market growth.

On the contrary, product recalls hamper the growth of Europe spinal cord stimulation device for chronic pain market.

Based on product type, the Europe spinal cord stimulation device for chronic pain market is bifurcated into rechargeable and non-rechargeable. The rechargeable segment held 72.6% share of the Europe spinal cord stimulation device for chronic pain market in 2022, amassing US$ 580.52 million. It is projected to garner US$ 1,042.85 million by 2030 to expand at 7.6% CAGR during 2022-2030.

In terms of application, the Europe spinal cord stimulation device for chronic pain market is segmented into failed back syndrome, complex regional pain syndrome, degenerative disk disease, and others. The complex regional pain syndrome segment held 40.3% share of the Europe spinal cord stimulation device for chronic pain market in 2022, amassing US$ 322.63 million. It is estimated to garner US$ 563.40 million by 2030 to expand at 7.2% CAGR during 2022-2030.

By end user, the Europe spinal cord stimulation device for chronic pain market is segmented into hospitals, ambulatory surgery centers (ASCS), and others. The hospitals segment held 68.2% share of Europe spinal cord stimulation device for chronic pain market in 2022, amassing US$ 545.48 million. It is predicted to garner US$ 970.56 million by 2030 to expand at 7.5% CAGR during 2022-2030.

Based on country, the Europe spinal cord stimulation device for chronic pain market is categorized into Germany, France, United Kingdom, Spain, Italy, Switzerland, Sweden, Poland, Belgium, Slovakia, Czech Republic, Greece, Ireland, the Netherland, and the Rest of Europe. Germany held 21.3% share of Europe spinal cord stimulation device for chronic pain market in 2022, amassing US$ 170.70 million. It is projected to garner US$ 311.52 million by 2030 to expand at 7.8% CAGR during 2022-2030.

Key players operating in the Europe spinal cord stimulation device for chronic pain market are Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE & Co KG, Nevro Corp, Cirtec Medical Corp, and Synapse Biomedical Inc, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe spinal cord stimulation device for chronic pain market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Europe spinal cord stimulation device for chronic pain market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS

1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
1.2.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market – by Product Type
1.2.2 Europe Spinal Cord Stimulation Device for Chronic Pain Market – by Application
1.2.3 Europe Spinal Cord Stimulation Device for Chronic Pain Market – by End User
1.2.4 Europe Spinal Cord Stimulation Device for Chronic Pain Market – by Country
2. Europe Spinal Cord Stimulation Device for Chronic Pain Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Spinal Cord Stimulation Device for Chronic Pain Market – Market Landscape
4.1 Company Share Analysis
4.2 Pricing Analysis
5. Europe Spinal Cord Stimulation Device for Chronic Pain Market
5.1 Market Drivers
5.1.1 Rising Number of Spinal Cord Injuries
5.1.2 Availability of Innovative Treatments in European Union
5.2 Market Restraints
5.2.1 Product Recalls
5.3 Market Opportunities
5.3.1 Rehabilitation and Specialized Centers Providing Effective Treatment for Spinal Cord Injuries
5.4 Future Trends
5.4.1 Regenerative and Innovative Implant-Based Therapeutic Approaches
5.5 Impact analysis
6. Spinal Cord Stimulation Device for Chronic Pain Market – Europe Analysis
6.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Forecast and Analysis
7. Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 – by Product Type
7.1 Overview
7.2 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Product Type, 2022 & 2030 (%)
7.3 Rechargeable
7.3.1 Overview
7.3.2 Rechargeable: Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Rechargeable
7.4.1 Overview
7.4.2 Non-Rechargeable: Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts to 2030- by Application
8.1 Overview
8.1.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Application (2022 and 2030)
8.2 Failed Back Syndrome
8.2.1 Overview
8.2.2 Failed Back Syndrome: Europe Spinal Cord Stimulation Device for Chronic Pain Market- Revenue and Forecast to 2030 (US$ Million)
8.3 Complex Regional Pain Syndrome
8.3.1 Overview
8.3.2 Complex Regional Pain Syndrome: Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Degenerative Disk Disease
8.4.1 Overview
8.4.2 Degenerative Disk Disease: Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts to 2030- by End User
9.1 Overview
9.2 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by End User (2022 and 2030)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Europe Spinal Cord Stimulation Device for Chronic Pain Market- Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgery Centers (ASCs)
9.4.1 Overview
9.4.2 Ambulatory Surgery Centers (ASCs): Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 -Country Analysis
10.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.1.1 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Countries
10.1.1.2 Germany
10.1.1.2.1 Overview
10.1.1.2.2 Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.2.4 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.2.5 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.1.3 France
10.1.1.3.1 Overview
10.1.1.3.2 France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 France: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.3.4 France: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.3.5 France: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.1.4 Italy
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.4.4 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.4.5 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.1.5 Spain
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.3 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.5.4 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.5.5 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.1.6 United Kingdom
10.1.1.6.1 Overview
10.1.1.6.2 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.3 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.6.4 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.6.5 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.1.7 Switzerland
10.1.1.7.1 Overview
10.1.1.7.2 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.7.3 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.7.4 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.7.5 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.1.8 Netherlands
10.1.1.8.1 Overview
10.1.1.8.2 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.8.3 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.8.4 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.8.5 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.1.9 Sweden
10.1.1.9.1 Overview
10.1.1.9.2 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.9.3 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.9.4 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.9.5 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.1.10 Belgium
10.1.1.10.1 Overview
10.1.1.10.2 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.10.3 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.10.4 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.10.5 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.1.11 Poland
10.1.1.11.1 Overview
10.1.1.11.2 Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.11.3 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.11.4 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.11.5 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.1.12 Slovakia
10.1.1.12.1 Overview
10.1.1.12.2 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.12.3 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.12.4 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.12.5 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.1.13 Czech Republic
10.1.1.13.1 Overview
10.1.1.13.2 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.13.3 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.13.4 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.13.5 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.1.14 Greece
10.1.1.14.1 Overview
10.1.1.14.2 Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.14.3 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.14.4 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.14.5 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.1.15 Ireland
10.1.1.15.1 Overview
10.1.1.15.2 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.15.3 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.15.4 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.15.5 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
10.1.1.16 Rest of Europe
10.1.1.16.1 Overview
10.1.1.16.2 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.16.3 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
10.1.1.16.4 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
10.1.1.16.5 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Boston Scientific Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Abbott Laboratories
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Medtronic Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Biotronik SE & Co KG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Nevro Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Cirtec Medical Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Synapse Biomedical Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The the Reporting Teams
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Spinal Cord Stimulation Device for Chronic Pain Market Segmentation
Table 2. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 3. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 4. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 5. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 6. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 7. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 8. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 9. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 10. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 11. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 12. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 13. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 14. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 15. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 16. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 17. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 18. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 19. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 20. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 21. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 22. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 23. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 24. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 25. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 26. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 27. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 28. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 29. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 30. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 31. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 32. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 33. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 34. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 35. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 36. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 37. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 38. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 39. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 40. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 41. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 42. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 43. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 44. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Product Type
Table 45. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – Application
Table 46. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 47. Organic Developments Done By Companies
Table 48. Inorganic Developments Done By Companies
Table 49. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Spinal Cord Stimulation Device for Chronic Pain Market, by Country
Figure 2. Key Insights
Figure 3. Europe Spinal Cord Stimulation Device Market for Chronic Pain: Company Share Analysis
Figure 4. Europe Spinal Cord Stimulation Device Market for Chronic Pain: Pricing Analysis
Figure 5. Europe Spinal Cord Stimulation Device for Chronic Pain Market- Key Industry Dynamics
Figure 6. Europe Spinal Cord Stimulation Device for Chronic Pain Market: Impact Analysis of Drivers and Restraints
Figure 7. Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue Forecast and Analysis – 2020-2030
Figure 8. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Product Type, 2022 & 2030 (%)
Figure 9. Rechargeable: Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Non-Rechargeable: Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Application (2022 and 2030)
Figure 12. Failed Back Syndrome: Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Complex Regional Pain Syndrome: Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Degenerative Disk Disease: Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by End User (2022 and 2030)
Figure 17. Hospitals: Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ambulatory Surgery Centers (ASCs): Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Spinal Cord Stimulation Device for Chronic Pain Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Spinal Cord Stimulation Device for Chronic Pain Market, Country 2022 ($Mn)
Figure 21. Europe: Spinal Cord Stimulation Device for Chronic Pain Market, By Key Countries, 2022 And 2030 (%)
Figure 22. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 36. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
Figure 37. Growth Strategies Done by the Companies in the Market (%)

The List of Companies – Europe Spinal Cord Stimulation Device for Chronic Pain Market

1. Boston Scientific Corp
2. Abbott Laboratories
3. Medtronic Plc
4. Biotronik SE & Co KG
5. Nevro Corp
6. Cirtec Medical Corp
7. Synapse Biomedical Inc

Reviews

There are no reviews yet.

Be the first to review “Europe Spinal Cord Stimulation Device for Chronic Pain Market Forecast to 2030”